Cristina Cadenas

3.6k total citations
33 papers, 1.3k citations indexed

About

Cristina Cadenas is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Cristina Cadenas has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Cristina Cadenas's work include Liver Disease Diagnosis and Treatment (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Cancer Cells and Metastasis (4 papers). Cristina Cadenas is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Cancer Cells and Metastasis (4 papers). Cristina Cadenas collaborates with scholars based in Germany, Egypt and United Kingdom. Cristina Cadenas's co-authors include Jan G. Hengstler, Jörg Rahnenführer, Rosemarie Marchan, Birte Hellwig, Marcus Schmidt, Miriam Lohr, Karolina Edlund, Henrik Oster, Joanna D. Stewart and Wiebke Schormann and has published in prestigious journals such as Neuron, The Journal of Immunology and PLoS ONE.

In The Last Decade

Cristina Cadenas

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Cadenas Germany 20 636 280 195 178 170 33 1.3k
Thaiz F. Borin United States 22 688 1.1× 259 0.9× 406 2.1× 209 1.2× 300 1.8× 54 1.4k
Bo‐Hwa Choi South Korea 20 740 1.2× 285 1.0× 132 0.7× 201 1.1× 55 0.3× 49 1.3k
Pierpaolo Coluccia Italy 23 655 1.0× 217 0.8× 213 1.1× 57 0.3× 79 0.5× 36 1.3k
Yukiko Kaneko Japan 16 651 1.0× 208 0.7× 112 0.6× 160 0.9× 119 0.7× 48 1.6k
Kerstin Krause Germany 24 679 1.1× 293 1.0× 156 0.8× 91 0.5× 71 0.4× 70 1.7k
Madhavika N. Serasinghe United States 15 949 1.5× 142 0.5× 245 1.3× 174 1.0× 69 0.4× 17 1.3k
Alejandra Tomás United Kingdom 27 1.5k 2.4× 233 0.8× 141 0.7× 129 0.7× 61 0.4× 61 2.4k
Dongyin Guan United States 20 586 0.9× 189 0.7× 156 0.8× 94 0.5× 358 2.1× 33 1.3k
Néstor Prieto‐Domínguez Spain 12 466 0.7× 118 0.4× 151 0.8× 100 0.6× 153 0.9× 12 774
Adarsh Shankar United States 16 307 0.5× 123 0.4× 174 0.9× 120 0.7× 160 0.9× 24 761

Countries citing papers authored by Cristina Cadenas

Since Specialization
Citations

This map shows the geographic impact of Cristina Cadenas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Cadenas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Cadenas more than expected).

Fields of papers citing papers by Cristina Cadenas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Cadenas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Cadenas. The network helps show where Cristina Cadenas may publish in the future.

Co-authorship network of co-authors of Cristina Cadenas

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Cadenas. A scholar is included among the top collaborators of Cristina Cadenas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Cadenas. Cristina Cadenas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Begher‐Tibbe, Brigitte, Jörg Reinders, Cristina Cadenas, et al.. (2024). EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis. Breast Cancer Research. 26(1). 87–87. 1 indexed citations
2.
Kwon, Y.K., Pascal Gottmann, Revathi Sekar, et al.. (2024). Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology. 82(1). 18–27. 10 indexed citations
3.
Gajewski, Patrick D., Stephan Getzmann, Peter Bröde, et al.. (2021). Impact of Biological and Lifestyle Factors on Cognitive Aging and Work Ability in the Dortmund Vital Study: Protocol of an Interdisciplinary, Cross-sectional, and Longitudinal Study. JMIR Research Protocols. 11(3). e32352–e32352. 24 indexed citations
4.
Barghash, Ahmad, Sascha Tierling, Norbert Naß, et al.. (2019). IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis. Frontiers in Medicine. 6. 179–179. 16 indexed citations
5.
Gu, Xiaolong, Wiebke Albrecht, Karolina Edlund, et al.. (2018). Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes. Archives of Toxicology. 92(12). 3505–3515. 23 indexed citations
6.
Salhab, Abdulrahman, Karl Nordström, Gilles Gasparoni, et al.. (2018). A comprehensive analysis of 195 DNA methylomes reveals shared and cell-specific features of partially methylated domains. Genome biology. 19(1). 59 indexed citations
7.
Schriewer, Alexander, et al.. (2017). Oxalic acid quantification in mouse urine and primary mouse hepatocyte cell culture samples by ion exclusion chromatography–mass spectrometry. Journal of Chromatography B. 1068-1069. 239–244. 12 indexed citations
9.
Edlund, Karolina, Kathrin Gianmoena, Rosemarie Marchan, et al.. (2016). Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway. Analytical and Bioanalytical Chemistry. 409(6). 1591–1606. 26 indexed citations
10.
Arbo, Marcelo Dutra, Regina Stöber, Markus Schug, et al.. (2016). Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis. Archives of Toxicology. 90(12). 3045–3060. 17 indexed citations
11.
Edlund, Karolina, Marianna Grinberg, Seddik Hammad, et al.. (2015). Gelsolin Is Associated with Longer Metastasis-free Survival and Reduced Cell Migration in Estrogen Receptor-positive Breast Cancer.. PubMed. 35(10). 5277–85. 16 indexed citations
12.
Cadenas, Cristina, Karolina Edlund, Miriam Lohr, et al.. (2014). Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 13(20). 3282–3291. 148 indexed citations
13.
Kessler, Sonja M., Katja Gemperlein, Kathrin Gianmoena, et al.. (2014). Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences. 15(4). 5762–5773. 40 indexed citations
14.
Lohr, Miriam, Karolina Edlund, Johan Botling, et al.. (2013). The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Letters. 333(2). 222–228. 146 indexed citations
15.
Cadenas, Cristina, et al.. (2012). ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cells. Cytoskeleton. 69(5). 267–277. 9 indexed citations
16.
Siggelkow, Wulf, Daniel Boehm, Susanne Gebhard, et al.. (2012). Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients. BMC Cancer. 12(1). 562–562. 45 indexed citations
17.
Godoy, Patrício, Cristina Cadenas, Birte Hellwig, et al.. (2012). Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer. 21(4). 491–499. 70 indexed citations
18.
Chen, Zonglin, Aslihan Gerhold‐Ay, Susanne Gebhard, et al.. (2012). Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer. PLoS ONE. 7(9). e44741–e44741. 30 indexed citations
19.
Cadenas, Cristina, Marcus Schmidt, Mathias Gehrmann, et al.. (2010). Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Research. 12(3). R44–R44. 143 indexed citations
20.
Frimat, Jean‐Philippe, Joanna D. Stewart, Wiebke Schormann, et al.. (2010). Microarrays for the scalable production of metabolically relevant tumour spheroids: a tool for modulating chemosensitivity traits. Lab on a Chip. 11(3). 419–428. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026